PhaseBio Pharmaceuticals Says On Oct. 25, 2022 Co. Received Notice From Nasdaq Stating It Has Determined That Co.'s Securities Will Be Delisted From Nasdaq
PhaseBio Pharmaceuticals Says On Oct. 25, 2022 Co. Received Notice From Nasdaq Stating It Has Determined That Co.'s Securities Will Be Delisted From Nasdaq
PhaseBio制药公司表示,2022年10月25日,公司收到纳斯达克的通知,表示已决定公司的证券将从纳斯达克退市
PhaseBio Pharmaceuticals Says On Oct. 25, 2022 Co. Received Notice From Nasdaq Stating It Has Determined That Co.'s Securities Will Be Delisted From Nasdaq
PhaseBio制药公司表示,2022年10月25日,公司收到纳斯达克的通知,表示已决定公司的证券将从纳斯达克退市